Skip to main content

Table 3 Cox proportional hazard regression comparing mortality and hospitalizations among patients with idiopathic pulmonary fibrosis with and without metformin use

From: Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis

  

Rate per 100 (95% CI)

   
 

Before propensity score matching

After propensity score matching

Hazard ratio (95% CI)

p value

 

No metformin (n = 2222)

Metformin (n = 1377)

No metformin (n = 1100)

Metformin (n = 1100)

Death

25.1 (23.3, 27.1)

10.5 (8.7, 12.5)

20.6 (18.4, 23.2)

10.5 (8.5, 12.8)

0.46 (0.36, 0.58)

 < 0.001

Hospitalization

76.1 (72.0, 80.6)

55.12 (50.4, 60.3)

64.3 (59.2, 69.9)

57.8 (52.4, 63.8)

0.82 (0.72, 0.93)

0.003